Author

Robbe C. Lyon

Observed names: Lyon, Robbe C., R C Lyon, R. C. LYON, R. C. Lyon, R.C. Lyon, ROBBE C. LYON, Robbe Lyon

Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research

Observed institutions: National Institutes of Health, United States Food and Drug Administration, Center for Drug Evaluation and Research, Substance Abuse and Mental Health Services Administration, Howard University, Philip Morris International (Switzerland), QRx Pharma (United States), National Institute on Alcohol Abuse and Alcoholism, Stanford Medicine, National Cancer Institute, Food and Drug Administration, Stanford University

OpenAlex ID: A5089254256

Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy.

1987 · P F Daly, R C Lyon, et al. · Journal of Biological Chemistry · 254

A relationship between alcohol intoxication and the disordering of brain membranes by a series of short-chain alcohols.

1981 · R C Lyon, J A McComb, et al. · Journal of Pharmacology and Experimental Therapeutics · 209

Near-infrared spectral imaging for quality assurance of pharmaceutical products: Analysis of tablets to assess powder blend homogeneity

2002 · Robbe C. Lyon, David S. Lester, et al. · AAPS PharmSciTech · 192

PDF

Quantitative determination of cesium binding to ferric hexacyanoferrate: Prussian blue

2008 · Patrick J. Faustino, Yongsheng Yang, et al. · Journal of Pharmaceutical and Biomedical Analysis · 148

Stability profiles of drug products extended beyond labeled expiration dates

2006 · Robbe C. Lyon, Jeb S. Taylor, et al. · Journal of Pharmaceutical Sciences · 138

Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism.

1990 · O Kaplan, G Navon, et al. · PubMed · 124

Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy.

1988 · R C Lyon, J S Cohen, et al. · PubMed · 124

In Vivo measurement of cerebral oxygen consumption and blood flow using 17O magnetic resonance imaging

1991 · J. Pekar, L. Ligeti, et al. · Magnetic Resonance in Medicine · 122

Tissue distribution and stability of metalloporphyrin MRI contrast agents

1987 · R. C. Lyon, P. J. Faustino, et al. · Magnetic Resonance in Medicine · 113

Biopharmaceutics Classification of Selected β-Blockers: Solubility and Permeability Class Membership

2007 · Yongsheng Yang, Patrick J. Faustino, et al. · Molecular Pharmaceutics · 101

Differences in phosphate metabolite levels in drug-sensitive and -resistant human breast cancer cell lines determined by 31P magnetic resonance spectroscopy.

1986 · J S Cohen, R C Lyon, et al. · PubMed · 100

Ethanol disordering of spin-labeled mouse brain membranes: correlation with genetically determined ethanol sensitivity of mice.

1982 · D B Goldstein, J H Chin, et al. · Proceedings of the National Academy of Sciences · 97

Quality assessment of internet pharmaceutical products using traditional and non-traditional analytical techniques

2005 · Benjamin J. Westenberger, Christopher D. Ellison, et al. · International Journal of Pharmaceutics · 81

Changes in synaptic membrane order associated with chronic ethanol treatment in mice.

1983 · R C Lyon, D B Goldstein · Molecular Pharmacology · 76

31 P‐NMR spectroscopy of human cancer cells proliferating in a basement membrane gel

1988 · Peter F. Daly, Robbe C. Lyon, et al. · The FASEB Journal · 70

Measuring the distribution of density and tabletting force in pharmaceutical tablets by chemical imaging

2008 · Christopher D. Ellison, Bryan J. Ennis, et al. · Journal of Pharmaceutical and Biomedical Analysis · 62

Quantitative molecular analysis with molecular bands emission using laser-induced breakdown spectroscopy and chemometrics

2008 · François R. Doucet, Patrick J. Faustino, et al. · Journal of Analytical Atomic Spectrometry · 56

PDF

Double‐quantum surface‐coil NMR studies of sodium and potassium in the rat brain

1991 · Robbe C. Lyon, James Pekar, et al. · Magnetic Resonance in Medicine · 55

Studies on the mechanism of selective retention of porphyrins and metalloporphyrins by cancer cells

1987 · Frederique Megnin, Patrick J. Faustino, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 53

Quality-by-Design (QbD): Effects of Testing Parameters and Formulation Variables on the Segregation Tendency of Pharmaceutical Powder Measured by the ASTM D 6940-04 Segregation Tester

2008 · Lin Xie, Huiquan Wu, et al. · Journal of Pharmaceutical Sciences · 51

In vivo17O NMR study of rat brain during 17O2 inhalation

1992 · D. Fiat, L. Ligeti, et al. · Magnetic Resonance in Medicine · 46

Drug product characterization by Macropixel Analysis of chemical images

2007 · Mazen L. Hamad, Christopher D. Ellison, et al. · Journal of Pharmaceutical Sciences · 41

A perfusion technique for 13C NMR studies of the metabolism of 13C‐labeled substrates by mammalian cells

1986 · Robbe C. Lyon, Patrick J. Faustino, et al. · Magnetic Resonance in Medicine · 34

NIR Spectroscopy Applications in the Development of a Compacted Multiparticulate System for Modified Release

2011 · Stuart L. Cantor, Stephen W. Hoag, et al. · AAPS PharmSciTech · 33

PDF

Increased surface glycoconjugates of synaptic membranes in mice during chronic ethanol treatment

1983 · Dora B. Goldstein, Basalingappa L. Hungund, et al. · British Journal of Pharmacology · 32

PDF

Works count: 55

Citation count: 2,694

H-index: 28

I10-index: 38